AI-Powered Segmentation of Invasive Carcinoma Regions in Breast Cancer Immunohistochemical Whole-Slide Images

Author:

Liu Yiqing1ORCID,Zhen Tiantian2,Fu Yuqiu1,Wang Yizhi1,He Yonghong1,Han Anjia2ORCID,Shi Huijuan2

Affiliation:

1. Institute of Biopharmaceutical and Health Engineering, Tsinghua Shenzhen International Graduate School, Shenzhen 518055, China

2. Department of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China

Abstract

Aims: The automation of quantitative evaluation for breast immunohistochemistry (IHC) plays a crucial role in reducing the workload of pathologists and enhancing the objectivity of diagnoses. However, current methods face challenges in achieving fully automated immunohistochemistry quantification due to the complexity of segmenting the tumor area into distinct ductal carcinoma in situ (DCIS) and invasive carcinoma (IC) regions. Moreover, the quantitative analysis of immunohistochemistry requires a specific focus on invasive carcinoma regions. Methods and Results: In this study, we propose an innovative approach to automatically identify invasive carcinoma regions in breast cancer immunohistochemistry whole-slide images (WSIs). Our method leverages a neural network that combines multi-scale morphological features with boundary features, enabling precise segmentation of invasive carcinoma regions without the need for additional H&E and P63 staining slides. In addition, we introduced an advanced semi-supervised learning algorithm, allowing efficient training of the model using unlabeled data. To evaluate the effectiveness of our approach, we constructed a dataset consisting of 618 IHC-stained WSIs from 170 cases, including four types of staining (ER, PR, HER2, and Ki-67). Notably, the model demonstrated an impressive intersection over union (IoU) score exceeding 80% on the test set. Furthermore, to ascertain the practical utility of our model in IHC quantitative evaluation, we constructed a fully automated Ki-67 scoring system based on the model’s predictions. Comparative experiments convincingly demonstrated that our system exhibited high consistency with the scores given by experienced pathologists. Conclusions: Our developed model excels in accurately distinguishing between DCIS and invasive carcinoma regions in breast cancer immunohistochemistry WSIs. This method paves the way for a clinically available, fully automated immunohistochemistry quantitative scoring system.

Funder

National Natural Science Foundation of China

Shenzhen Science and Technology Innovation Commission

Jilin Fuyuan Guan Food Group Co., Ltd.

Publisher

MDPI AG

Subject

Cancer Research,Oncology

Reference40 articles.

1. Global Cancer Statistics 2022: The trends projection analysis;Chhikara;Chem. Biol. Lett.,2023

2. WHO (2019). WHO Classification of Tumors–Breast Tumors, International Agency for Research on Cancer. [5th ed.].

3. Comparison of breast cancer risk factors among molecular subtypes: A case-only study;Zhang;Cancer Med.,2019

4. Significance of immunohistochemistry in breast cancer;Zaha;World J. Clin. Oncol.,2014

5. Dabbs, D.J. (2021). Diagnostic Immunohistochemistry E-Book: Theranostic and Genomic Applications, Elsevier.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3